 
					Global Cystoscope Market Size Study, by Product (Flexible Cystoscopes, Rigid Cystoscopes), by Application (Urology, Gynecology), by End Use (Hospitals, Diagnostic Imaging Centers, Ambulatory Surgery Centers), by Type (Video Cystoscopes, Fiberoptic Cystosc
Description
						The global cystoscope market was valued at approximately USD 1.23 billion in 2024 and is projected to grow at a CAGR of 10.5%  from 2024 to 2034. The increasing prevalence of urological and gynecological disorders, a growing geriatric population, and technological advancements in cystoscope devices are key factors driving the market.
Cystoscopes are widely used for the diagnosis and treatment of urinary tract disorders, bladder cancer, urinary incontinence, and urinary tract infections (UTIs). According to a 2024 study published by Elsevier Inc., 50% -60% of women experience at least one UTI in their lifetime, significantly increasing the demand for cystoscopic procedures. Additionally, a WHO report (2024) estimates that by 2030, around 16.66% of the global population will be aged 60 or older, contributing to a higher prevalence of urological conditions such as benign prostatic hyperplasia (BPH), bladder stones, and bladder cancer.
The rising incidence of bladder cancer is also a major growth driver for the cystoscope market. The International Agency for Research on Cancer (2022) reported that over 600,000 people worldwide were diagnosed with bladder cancer, leading to more than 220,000 deaths. Since cystoscopy is the primary diagnostic tool for bladder cancer, the increasing disease burden is expected to propel market demand over the forecast period.
Technological innovations are transforming cystoscopy procedures, improving patient comfort and diagnostic accuracy. For instance, UroViu Corp introduced the Uro-GHD in April 2024, a single-use, sterile cystoscope designed for enhanced flexibility and improved patient comfort. Additionally, Ambu Inc. received FDA approval for the aScope 4 Cysto in 2021, expanding the availability of video cystoscopy solutions. The adoption of single-use cystoscopes is rising due to infection control concerns, reducing the risk of cross-contamination and healthcare-associated infections (HAIs).
From a regional perspective, North America held the largest market share in 2024, driven by advanced healthcare infrastructure, increasing incidence of bladder cancer, and strong presence of key market players such as Olympus Corporation, Boston Scientific Corporation, and Ambu Inc.. Meanwhile, the Asia Pacific region is projected to witness the fastest growth, fueled by rising healthcare investments, increasing awareness of urological disorders, and expanding access to diagnostic facilities in countries such as China, India, and Japan.
Major Market Players Included in This Report:
By Product:
North America
							
						
					
				Cystoscopes are widely used for the diagnosis and treatment of urinary tract disorders, bladder cancer, urinary incontinence, and urinary tract infections (UTIs). According to a 2024 study published by Elsevier Inc., 50% -60% of women experience at least one UTI in their lifetime, significantly increasing the demand for cystoscopic procedures. Additionally, a WHO report (2024) estimates that by 2030, around 16.66% of the global population will be aged 60 or older, contributing to a higher prevalence of urological conditions such as benign prostatic hyperplasia (BPH), bladder stones, and bladder cancer.
The rising incidence of bladder cancer is also a major growth driver for the cystoscope market. The International Agency for Research on Cancer (2022) reported that over 600,000 people worldwide were diagnosed with bladder cancer, leading to more than 220,000 deaths. Since cystoscopy is the primary diagnostic tool for bladder cancer, the increasing disease burden is expected to propel market demand over the forecast period.
Technological innovations are transforming cystoscopy procedures, improving patient comfort and diagnostic accuracy. For instance, UroViu Corp introduced the Uro-GHD in April 2024, a single-use, sterile cystoscope designed for enhanced flexibility and improved patient comfort. Additionally, Ambu Inc. received FDA approval for the aScope 4 Cysto in 2021, expanding the availability of video cystoscopy solutions. The adoption of single-use cystoscopes is rising due to infection control concerns, reducing the risk of cross-contamination and healthcare-associated infections (HAIs).
From a regional perspective, North America held the largest market share in 2024, driven by advanced healthcare infrastructure, increasing incidence of bladder cancer, and strong presence of key market players such as Olympus Corporation, Boston Scientific Corporation, and Ambu Inc.. Meanwhile, the Asia Pacific region is projected to witness the fastest growth, fueled by rising healthcare investments, increasing awareness of urological disorders, and expanding access to diagnostic facilities in countries such as China, India, and Japan.
Major Market Players Included in This Report:
- Olympus Corporation
- Boston Scientific Corporation
- Ambu Inc.
- KARL STORZ
- Advin Health Care
- Intuitive Surgical (SCHÖLLY FIBEROPTIC GMBH)
- Stryker
- UroViu Corporation
- NeoScope Inc.
- OTU Medical
- HOYA Corporation (Pentax Medical)
By Product:
- Flexible Cystoscopes
- Rigid Cystoscopes
- Urology
- Gynecology
- Hospitals
- Diagnostic Imaging Centers
- Ambulatory Surgery Centers
- Others
- Video Cystoscopes
- Fiberoptic Cystoscopes
North America
- U.S.
- Canada
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Rest of Europe
- Japan
- China
- India
- Australia
- South Korea
- Thailand
- Rest of Asia Pacific
- Brazil
- Argentina
- Colombia
- Rest of Latin America
- Saudi Arabia
- UAE
- South Africa
- Kuwait
- Rest of Middle East & Africa
- Historical Year – 2022
- Base Year – 2024
- Forecast Period – 2024 to 2034
- Market Estimates & Forecast for 10 years (2022-2034).
- Annualized revenue projections and regional analysis for each market segment.
- Comprehensive geographical landscape analysis with country-level insights.
- Competitive landscape review, including leading market players.
- Strategic recommendations for future market approaches.
- Detailed analysis of market structure and competitive dynamics.
- In-depth demand-side and supply-side market assessments.
Table of Contents
										285 Pages
									
							- Chapter 1. Global Cystoscope Market Executive Summary
- 1.1. Global Cystoscope Market Size & Forecast (2024-2034)
- 1.2. Regional Summary
- 1.3. Segmental Summary
- 1.3.1. By Product
- 1.3.2. By Application
- 1.3.3. By End Use
- 1.3.4. By Type
- 1.4. Key Market Trends
- 1.5. Recession Impact
- 1.6 Industry Metrics
- 1.7 Investment Analysis
- 1.8 Investment Rationale
- 1.9. Analyst Recommendation & Conclusion
- Chapter 2. Global Cystoscope Market Definition and Research Assumptions
- 2.1. Research Objective
- 2.2. Market Definition
- 2.3. Research Assumptions
- 2.3.1. Inclusion & Exclusion
- 2.3.2. Limitations
- 2.3.3. Supply Side Analysis
- 2.3.3.1. Availability
- 2.3.3.2. Infrastructure
- 2.3.3.3. Regulatory Environment
- 2.3.3.4. Market Competition
- 2.3.3.5. Economic Viability (Consumer’s Perspective)
- 2.3.4. Demand Side Analysis
- 2.3.4.1. Regulatory Frameworks
- 2.3.4.2. Technological Advancements
- 2.3.4.3. Environmental Considerations
- 2.3.4.4. Consumer Awareness & Acceptance
- 2.4. Estimation Methodology
- 2.5. Years Considered for the Study
- 2.6. Currency Conversion Rates
- Chapter 3. Global Cystoscope Market Dynamics
- 3.1. Market Drivers
- 3.1.1. Increasing Prevalence of Urological and Gynecological Disorders
- 3.1.2. Growing Geriatric Population and Rising Cases of Urinary Incontinence
- 3.1.3. Technological Advancements in Cystoscope Devices
- 3.2. Market Challenges
- 3.2.1. High Cost of Advanced Cystoscope Devices
- 3.2.2. Stringent Regulatory Compliance & Safety Standards
- 3.3. Market Opportunities
- 3.3.1. Rising Demand for Minimally Invasive Procedures
- 3.3.2. Increasing Adoption of Single-Use Cystoscopes
- Chapter 4. Global Cystoscope Market Industry Analysis
- 4.1. Porter’s Five Forces Analysis
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter’s Five Forces Model
- 4.1.7. Porter’s Five Forces Impact Analysis
- 4.2. PESTEL Analysis
- 4.2.1. Political Factors
- 4.2.2. Economic Factors
- 4.2.3. Social Factors
- 4.2.4. Technological Factors
- 4.2.5. Environmental Factors
- 4.2.6. Legal Factors
- 4.3. Investment & Funding Landscape
- 4.4. Top Investment Opportunities
- 4.5. Competitive Landscape & Key Market Strategies
- 4.6. Regulatory & Policy Framework
- 4.7. Industry Expert Perspective
- 4.8. Analyst Recommendation & Conclusion
- Chapter 5. Global Cystoscope Market Size & Forecasts by Product (2024-2034)
- 5.1. Segment Dashboard
- 5.2. Market Revenue Trend Analysis (2022 & 2032)
- 5.2.1. Flexible Cystoscopes
- 5.2.2. Rigid Cystoscopes
- Chapter 6. Global Cystoscope Market Size & Forecasts by Application (2024-2034)
- 6.1. Segment Dashboard
- 6.2. Market Revenue Trend Analysis (2022 & 2032)
- 6.2.1. Urology
- 6.2.2. Gynecology
- Chapter 7. Global Cystoscope Market Size & Forecasts by End Use (2024-2034)
- 7.1. Segment Dashboard
- 7.2. Market Revenue Trend Analysis (2022 & 2032)
- 7.2.1. Hospitals
- 7.2.2. Diagnostic Imaging Centers
- 7.2.3. Ambulatory Surgery Centers
- 7.2.4. Others
- Chapter 8. Global Cystoscope Market Size & Forecasts by Type (2024-2034)
- 8.1. Segment Dashboard
- 8.2. Market Revenue Trend Analysis (2022 & 2032)
- 8.2.1. Video Cystoscopes
- 8.2.2. Fiberoptic Cystoscopes
- Chapter 9. Global Cystoscope Market Size & Forecasts by Region (2024-2034)
- 9.1. North America
- 9.1.1. U.S.
- 9.1.2. Canada
- 9.1.3. Mexico
- 9.2. Europe
- 9.2.1. UK
- 9.2.2. Germany
- 9.2.3. France
- 9.2.4. Italy
- 9.2.5. Spain
- 9.2.6. Denmark
- 9.2.7. Sweden
- 9.2.8. Norway
- 9.2.9. Rest of Europe
- 9.3. Asia-Pacific
- 9.3.1. Japan
- 9.3.2. China
- 9.3.3. India
- 9.3.4. Australia
- 9.3.5. South Korea
- 9.3.6. Thailand
- 9.3.7. Rest of Asia-Pacific
- 9.4. Latin America
- 9.4.1. Brazil
- 9.4.2. Argentina
- 9.4.3. Rest of Latin America
- 9.5. Middle East & Africa
- 9.5.1. Saudi Arabia
- 9.5.2. UAE
- 9.5.3. South Africa
- 9.5.4. Kuwait
- 9.5.5. Rest of Middle East & Africa
- Chapter 10. Competitive Intelligence
- 10.1. Key Company SWOT Analysis
- 10.1.1. Olympus Corporation
- 10.1.2. Boston Scientific Corporation
- 10.1.3. Ambu Inc.
- 10.2. Market Strategies of Leading Players
- 10.3. Company Profiles
- 10.3.1. KARL STORZ
- 10.3.2. Advin Health Care
- 10.3.3. Intuitive Surgical (SCHÖLLY FIBEROPTIC GMBH)
- 10.3.4. Stryker
- 10.3.5. UroViu Corporation
- 10.3.6. NeoScope Inc.
- 10.3.7. OTU Medical
- 10.3.8. HOYA Corporation (Pentax Medical)
- Chapter 11. Research Process
- 11.1. Research Process
- 11.1.1. Data Mining
- 11.1.2. Analysis
- 11.1.3. Market Estimation
- 11.1.4. Validation
- 11.1.5. Publishing
- 11.2. Research Attributes
Pricing
Currency Rates 
		Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
		
	

